Carmat S.A (ALCAR) | Stock Overview & Key Data
Carmat S.A. | Small-cap | Healthcare
Carmat S.A. | Small-cap | Healthcare
Carmat S.A Performance Comparison
Stock Range
Today's Range
Low: €0.12
High: €0.13
on September 5, 2025
52 Week Range
Low: €0.09
High: €2.43
on September 2, 2025
on September 5, 2024
All-Time High: €159.25 on May 13, 2013
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€8.6M
EPS
-1.15
P/E Ratio (TTM)
-0.11
Forward P/E
-0.05
P/B Ratio
N/A
PEG Ratio
-0.05
Div. Yield
N/A
ROE
100.52%
Beta
1.369
Debt to Equity
-1.13
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-644.75%
Profit Margin
-336.56%
Returns and Earnings
Return on Assets (TTM)
-64.45%
Return on Equity (TTM)
100.52%
EBITDA
€-47.2M
Net Income (TTM)
€-51.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.17
Quarterly Revenue Growth (YoY)
12.80%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Carmat S.A ALCAR | 8.56M Small-cap | -29.41% | -60.00% | -85.54% | -86.36% | -89.29% | -94.83% | -99.11% | -99.37% |
| Guerbet S.A GBT | 341.56M Mid-cap | -7.69% | -6.57% | -6.34% | -27.27% | -28.36% | -41.55% | 2.89% | -30.81% |
| Eurobio Scientific ALERS | 253.36M Mid-cap | -0.39% | -0.79% | 1.00% | -0.39% | -0.20% | 1.81% | 40.28% | 120.52% |
| Median Technologies ALMDT | 87.76M Small-cap | -3.88% | 16.43% | 9.73% | -8.49% | -41.51% | -58.80% | -76.15% | -62.20% |
| Affluent Medical AFME | 59.19M Small-cap | -5.23% | 15.08% | -0.68% | 2.11% | 4.32% | -22.87% | -50.00% | -81.76% |
| Novacyt S.A ALNOV | 34.84M Small-cap | 0.00% | 0.00% | -18.97% | -21.67% | -22.95% | -59.48% | -56.48% | -86.05% |
Ownership & Short Interest
Insider Ownership
25.45%
Institutional Ownership
0.48%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2M
Average 90-Day Volume
1M
Warning: Undefined variable $nickname in /usr/local/lsws/wordpress/wp-content/themes/egnitech-devyara/templates/stock-overview.php on line 329
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALCAR's 52-week high and low?
- In the last 52 weeks, Carmat S.A reached a high of €2.43 (on September 5, 2024) and a low of €0.09 (on September 2, 2025).
- What is the market cap and P/E ratio for ALCAR?
- Curious about Carmat S.A's size and valuation? Its market capitalization stands at 8.56M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.11, and the forward P/E (looking ahead) is -0.05.
- Does ALCAR pay dividends? If so, what's the yield?
- As for dividends, Carmat S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Carmat S.A's main competitors or similar companies to consider before investing?
When looking at Carmat S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Guerbet S.A
GBT341.56M Healthcare Medical Devices -41.55% 2.89% Eurobio Scientific
ALERS253.36M Healthcare Medical Devices 1.81% 40.28% Median Technologies
ALMDT87.76M Healthcare Medical Devices -58.80% -76.15% Affluent Medical
AFME59.19M Healthcare Medical Devices -22.87% -50.00% Novacyt S.A
ALNOV34.84M Healthcare Medical Devices -59.48% -56.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Carmat S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Carmat S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 100.52%, the Debt to Equity ratio from the most recent quarter is -1.13, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALCAR?
- Looking at Carmat S.A's growth, its revenue over the trailing twelve months (TTM) was €7M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.80%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALCAR stock is held by insiders and institutions?
- Wondering who owns Carmat S.A stock? Company insiders (like executives and directors) hold about 25.45% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.